The opinions expressed by Entrepreneur contributors are their own.
You are reading Entrepreneur India, the international franchise of Entrepreneur Media.
Bversity, a Chennai-based edtech startup and India’s first biotech virtual university, has raised INR 1.5 crore in a seed round led by Native Angel Network and Suresh Sambandam (Founder and CEO of Kissflow) . Other major investors include Nagaraja Prakasam (Chairman, NAN), Andi Giri (CEO, Soft Square), Prabhat Vivekanandan (Director, Richmond Hospital), Ashok Bakthavachalam (Chairman, KG Group), Ranjith Chakkath (CEO, Ninja Media ), Satish Kumar (Chairman, Milky Mist), and other angel investors from India and the US will be used to build the team to build a user-friendly and trustworthy edtech platform offering masterclasses.
“The biotech industry is expected to grow to $150 billion by 2025 and we have seen an 8x increase in the number of new companies and jobs in the biotech industry over the past 3 years. We want to create a global biotech education brand CEO of Bversity Sudharsan V, co-founder and co-founder, said: “We will bring in the top 1% mentors in life sciences. We are also currently looking to raise our next round of investment to scale. “
Bversity’s unwavering mission is to develop a skilled biotech workforce of over 1 million trained by experts in the field by 2025. The fledgling start-up plans to launch its exclusive mastery program in the form of one of the largest BioConclave on 5th February 2023 at IIT Research Park, Chennai. The platform has built experiential learning outcomes for more than 76 colleges, serving more than 2,000 biotech students across India, the company said in a statement.
Founded in 2022 by Sudharsan V, Raghul Jagannathan, Godwin Immanuel and Saiganesh V, Bversity aims to bridge the industry-academic gap in the life sciences through community-led learning programmes.
